Xiankui Liu

963 total citations
28 papers, 641 citations indexed

About

Xiankui Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiankui Liu has authored 28 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiankui Liu's work include Cancer-related molecular mechanisms research (7 papers), DNA Repair Mechanisms (4 papers) and Renal cell carcinoma treatment (4 papers). Xiankui Liu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), DNA Repair Mechanisms (4 papers) and Renal cell carcinoma treatment (4 papers). Xiankui Liu collaborates with scholars based in China and Japan. Xiankui Liu's co-authors include Chuize Kong, Zeliang Li, Jianbin Bi, Zhe Zhang, Yuyan Zhu, Xiaolu Cui, Yu Zeng, Xuyong Lin, Zhenhua Li and Chiyuan Piao and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Cellular and Molecular Life Sciences.

In The Last Decade

Xiankui Liu

27 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiankui Liu China 18 445 348 109 73 69 28 641
Yuechun Zhu China 14 414 0.9× 248 0.7× 95 0.9× 71 1.0× 77 1.1× 31 678
Si Yang China 17 455 1.0× 206 0.6× 109 1.0× 41 0.6× 95 1.4× 43 702
Xiaolu Cui China 11 377 0.8× 210 0.6× 117 1.1× 49 0.7× 82 1.2× 16 512
Miaolong Lu China 12 364 0.8× 225 0.6× 74 0.7× 67 0.9× 87 1.3× 18 607
Xiaonian Cao China 15 380 0.9× 232 0.7× 93 0.9× 43 0.6× 112 1.6× 31 604
Jianling Xia China 13 369 0.8× 170 0.5× 81 0.7× 55 0.8× 133 1.9× 20 571
Jianwen Zhang China 16 382 0.9× 227 0.7× 69 0.6× 49 0.7× 140 2.0× 27 641
Mingsong Wang China 17 549 1.2× 284 0.8× 56 0.5× 53 0.7× 106 1.5× 33 761
Dianne J. Beveridge Australia 16 582 1.3× 275 0.8× 43 0.4× 75 1.0× 89 1.3× 24 848

Countries citing papers authored by Xiankui Liu

Since Specialization
Citations

This map shows the geographic impact of Xiankui Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiankui Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiankui Liu more than expected).

Fields of papers citing papers by Xiankui Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiankui Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiankui Liu. The network helps show where Xiankui Liu may publish in the future.

Co-authorship network of co-authors of Xiankui Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiankui Liu. A scholar is included among the top collaborators of Xiankui Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiankui Liu. Xiankui Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zeliang, Zeliang Li, Xiankui Liu, et al.. (2019). Inhibition of miR‐34a‐5p can rescue disruption of the p53‐DAPK axis to suppress progression of clear cell renal cell carcinoma. Molecular Oncology. 13(10). 2079–2097. 20 indexed citations
2.
Wang, Yu, et al.. (2019). Analysis of imaging and pathological features of renal neoplasms among different pathological types. Zhonghua miniao waike zazhi. 40(5). 374–379. 1 indexed citations
3.
Cui, Xiaolu, et al.. (2019). ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs. Cellular and Molecular Life Sciences. 77(6). 1135–1152. 17 indexed citations
4.
Zhang, Naiwen, Jianyu Yang, Yuyan Zhu, et al.. (2019). Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 111–111. 56 indexed citations
5.
Zhang, Xiaotong, Xi Liu, Jianbin Bi, et al.. (2019). The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer. Cancer Gene Therapy. 27(3-4). 189–202. 23 indexed citations
6.
Bi, Jianbin, Zeliang Li, Xiankui Liu, et al.. (2019). <p>miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK&ndash;PTEN axis</p>. OncoTargets and Therapy. Volume 12. 2713–2727. 18 indexed citations
7.
Gao, Zhipeng, Xiaojun Man, Zhenhua Li, et al.. (2019). Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma. Oncology Reports. 41(4). 2440–2452. 7 indexed citations
8.
Gao, Zhipeng, Xiaojun Man, Zhenhua Li, et al.. (2019). PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3. Cancer Gene Therapy. 27(6). 412–423. 35 indexed citations
9.
Chen, Qiguang, Wei Zhou, Shuqi Du, et al.. (2019). Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1α. Cancer Cell International. 19(1). 128–128. 23 indexed citations
10.
Yu, Shan, Meng Yu, Dan Sun, et al.. (2018). Bibliometric Analysis of Tumor Immunotherapy Studies. Medical Science Monitor. 24. 3405–3414. 31 indexed citations
11.
Liu, Jiao, Jianbin Bi, Zeliang Li, et al.. (2018). miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells. International Journal of Molecular Medicine. 41(3). 1765–1773. 21 indexed citations
12.
Yang, Jianyu, Naiwen Zhang, Yuyan Zhu, et al.. (2018). TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways. Biochemical and Biophysical Research Communications. 501(4). 913–919. 21 indexed citations
13.
Dong, Xiao, Chuize Kong, Xiankui Liu, et al.. (2018). GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma.. PubMed. 8(8). 1414–1426. 33 indexed citations
14.
Du, Yang, Chuize Kong, Yuyan Zhu, et al.. (2018). Knockdown of SNHG15 suppresses renal cell carcinoma proliferation and EMT by regulating the NF-κB signaling pathway. International Journal of Oncology. 53(1). 384–394. 34 indexed citations
15.
Zhang, Zhe, Guojun Zhang, Zhipeng Gao, et al.. (2017). Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer. BMC Cancer. 17(1). 861–861. 21 indexed citations
16.
Kong, Chuize, et al.. (2017). TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth. Oncology Reports. 38(4). 1967–1976. 36 indexed citations
17.
Shi, Jing, et al.. (2015). Systematic Analysis on the GSTM1 Null Phenotype and Prostate Cancer Risk in Chinese People. Asian Pacific Journal of Cancer Prevention. 16(5). 2009–2011. 2 indexed citations
18.
Dong, Xiao, Chuize Kong, Zhe Zhang, et al.. (2014). hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Urologic Oncology Seminars and Original Investigations. 32(6). 885–892. 10 indexed citations
19.
Liu, Xiankui, et al.. (2008). Experimental research on axisymmetric folded-combined cavity CO2 laser. Optics Communications. 281(13). 3553–3556. 6 indexed citations
20.
Liu, Haibo, Chuize Kong, Yu Zeng, et al.. (2008). Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment. Urologic Oncology Seminars and Original Investigations. 27(3). 277–283. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuechun Zhu Breakdown of academic impact, for papers by Si Yang Breakdown of academic impact, for papers by Xiaolu Cui Breakdown of academic impact, for papers by Miaolong Lu Breakdown of academic impact, for papers by Xiaonian Cao Breakdown of academic impact, for papers by Jianling Xia Breakdown of academic impact, for papers by Jianwen Zhang Breakdown of academic impact, for papers by Mingsong Wang Breakdown of academic impact, for papers by Dianne J. Beveridge
Rankless by CCL
2026